Loading company…
Riskpilot
← Back to search
Sign in
Get full access
NURDENT INVEST AS
AS
Active
Org 921140932
Bekkasinvegen 61, 2008 Fjerdingby
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2018
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
-52% vs 2023
Equity ratio
91.9%
Financial strength
Net profit 2024
NOK -51K
-106% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -51K
-52%
Net profit
NOK -51K
-106%
Total assets
NOK 1,9M
-13%
Equity
NOK 1,7M
-3%
Employees
0
—
Company information
Legal name
NURDENT INVEST AS
Org number
921140932
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10. juli 2018
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Porteføljeinvesteringer og hva som dermed er forbundet. Videre ved aksjetegning eller på annen måte å gjøre seg interessert i andre foretagender.
Contact
Address
Bekkasinvegen 61, 2008 Fjerdingby
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Rælingen
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
225
155
99
0
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
212
153
73
−33
−51
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
212
153
73
−33
−51
Net financials
388
0
0
910
−0
Profit before tax
600
153
73
877
−51
Tax
44
34
16
−0
−0
Net profit
556
120
57
877
−51
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
893
1 169
1 414
2 162
1 875
Equity
720
840
897
1 773
1 723
Long-term debt
0
0
181
68
131
Short-term debt
173
329
336
320
22
Total debt
173
329
517
388
153
Financial ratios
5-year trend
EBITDA margin
-5059600.0%
This company
15.8%
Market median
-32022885% vs market
2020
2024
Equity ratio
91.9%
This company
38.2%
Market median
+141% vs market
2020
2024
Return on equity
-2.9%
This company
18.4%
Market median
-116% vs market
2020
2024
Net profit margin
-5059700.0%
This company
8.1%
Market median
-62465532% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
BN
Burim Nurkasa
Chief Executive Officer
Chief Executive Officer
2018
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
NURDENT INVEST AS
(this company)
NYDALEN TANNLEGESENTER AS
Board network connections
Board members of NURDENT INVEST AS also hold positions in
0
other companies.
Person
Role here
Other companies
Burim Nurkasa
Chief Executive Officer
0 companies